References
- Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:151–165.
- Trautinger F, Eder J, Assaf C, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome Update 2017. Eur J Cancer. 2017;77:57–74.
- Spect L, Dabaja B, Illidge T, et al. Modern radiation therapy for primary cutaneous lymphoms: Field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92:32–39.
- Fujii K. New therapies and immunological findings in cutaneous T-cell lymphoma. Front Oncol. 2018;8:198
- Hoppe RT, Harrison C, Tavallae M, et al. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol. 2015;72:286–292.
- Chowdhary M, Chhabra AM, Kharod S, et al. Total skin electron beam therapy in the treatment of mycosis fungoides: a review of conventional and low-dose regimens. Clin Lymphoma Myeloma Leuk. 2016;16:662–671.
- Hoppe RT, Fuks Z, Bagshaw MA. The rationale for curative radiotherapy in mycosis fungoides. Int J Radiat Oncol Biol Phys. 1977; 2:843–851.
- Cotter GW, Baglan RJ, Wasserman TH, et al. Palliative radiation treatment of cutaneous mycosis fungoides – a dose response. Int J Radiat Oncol Biol Phys. 1983;9:1477–1480.
- Harrison C, Young J, Navi D, et al. Revisiting low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys. 2011;81:e651–e657.
- Lloyd S, Chen Z, Foss FM, et al. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides. J Am Acad Dermatol. 2013;69:537–543.
- Becker M, Hoppe RT, Knox SJ. Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Int J Radiat Oncol Biol Phys. 1995;32:1445–1449.
- Wilson LD, Quiros PA, Kolenik SA, et al. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996;35:69–73.
- Yu JB, Khan AM, Jones GW, et al. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides. A pilot study. Am J Clin Oncol. 2009;32:142–144.
- Chowdhary M, Song A, Zaorsky NG, et al. Total skin electron beam therapy in mycosis fungoides – a shift towards lower dose? Chin Clin Oncol. 2018;1–11.
- Kamstrup MR, Gniadecki R, Iversen L, et al. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis. Int J Radiat Oncol Biol Phys. 2015;92:138–143.
- Elsayad K, Kriz J, Moustakis C, et al. Total skin electron beam for primary cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys. 2015;93:1077–1086.
- Kroeger K, Elsayad K, Moustakis C, et al. Low-dose total skin electron beam therapy for cutaneous lymphoma: minimal risk of acute toxicities. Strahlenther Onkol. 2017;193:1024–1030.
- Rivers CI, Singh AK. Total skin electron beam therapy for mycosis fungoides revisited with adjuvant systemic therapy. Clin Lymphoma Myeloma Leuk. 2019;19:83–88